CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics. We are focused on creating and optimizing next-generation psychedelic-inspired medicines to treat mental health conditions.

What We Do

New Tryptamines & Compound Optimization

Small alterations to a compound’s chemical structure create large differences in its pharmacology. CaaMTech creates new compounds with optimized properties by experimentally determining the relationship between chemical structure and biological activity. CaaMTech is creating novel tryptamines that are specifically engineered to optimize desired effects while minimizing unwanted side-effects.

Drug Safety and Efficacy Screening

Modern consumers demand safe and effective drugs that produce consistent effects with every dose. CaaMTech screens both natural and synthetic tryptamines for safety and efficacy, both individually and in formulation. Our goal is for every consumer of psychedelic drugs to know exactly what compounds they are consuming and in what quantity.

Our Methods

Fundamental Science

CaaMTech is laying the scientific groundwork for the entire psychedelics industry by conducting fundamental research necessary to characterize and fully understand both long existing and newly synthesized tryptamines. We are filling a longstanding unmet need within the space for a comprehensive chemical and biological understanding of psychedelic compounds—from naturally occurring psychedelics currently being used in clinical trials to human-engineered molecules of the future.

Technological Innovation

CaaMTech uses the latest laboratory and computational technologies to drive the research and development of novel psychedelic drugs. Utilizing our combination of off-the-shelf and internally developed technological solutions, CaaMTech is unearthing previously undiscovered patterns in large datasets of chemical information and research results. We hope that our contributions create widespread opportunities for driving scientific research and efficiently developing the most effective psychedelic drugs possible.

Intellectual Property

Recognizing the importance of intellectual property to fund progress in the nascent psychedelics space, CaaMTech has built a comprehensive patent portfolio. CaaMTech’s research is creating unique opportunities for developing pioneering inventions that support a broad range of downstream applications.

CaaMTech is committed to distributing its intellectual contributions to the field amongst collaborators who share our vision for developing safe and effective psychedelic products. Toward our goal of improving the health and happiness of humankind, we will freely share our discoveries with scientific collaborators who share this mission.  CaaMTech will not engage in commercial relationships that stifle scientific progress or impede the development of safe and effective products.

Our Team

CaaMTech has carefully selected a diverse group of highly-skilled experts including scientists, healthcare professionals, and technologists at the forefront of their respective fields. Our team members have Ph.D., MBA, and JD degrees from top US and international universities including Princeton, Harvard, and Cornell. CaaMTech’s combined experience connects multiple industries, including branded and generic pharmaceutical companies, natural product innovation, Silicon Valley startups, intellectual property law, consumer product development, manufacturing, and distribution.